164 related articles for article (PubMed ID: 17694639)
1. Pyrogen testing of lipidic parenterals with a novel in vitro test--application of the IPT based on cryopreserved human whole blood.
Schindler S; Rosenberg U; Schlote D; Panse K; Kempe A; Fennrich S; Hartung T
Pharmeur Sci Notes; 2006 Aug; 2006(1):1-7. PubMed ID: 17694639
[TBL] [Abstract][Full Text] [Related]
2. International validation of pyrogen tests based on cryopreserved human primary blood cells.
Schindler S; Spreitzer I; Löschner B; Hoffmann S; Hennes K; Halder M; Brügger P; Frey E; Hartung T; Montag T
J Immunol Methods; 2006 Oct; 316(1-2):42-51. PubMed ID: 16996078
[TBL] [Abstract][Full Text] [Related]
3. Cryopreservation of human whole blood for pyrogenicity testing.
Schindler S; Asmus S; von Aulock S; Wendel A; Hartung T; Fennrich S
J Immunol Methods; 2004 Nov; 294(1-2):89-100. PubMed ID: 15604019
[TBL] [Abstract][Full Text] [Related]
4. In vitro pyrogenicity of Gram-positive bacteria--validation of the kit using fresh human whole blood.
François C; Neveu J; Sauvaire D; Bonnet PA; Tissier MH
Pharmeur Sci Notes; 2006 Aug; 2006(1):17-21. PubMed ID: 17694641
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the pyrogen tests in rabbits and with limulus lysate.
Ronneberger HJ
Dev Biol Stand; 1977; 34():27-36. PubMed ID: 838147
[TBL] [Abstract][Full Text] [Related]
6. Comparison and validation of novel pyrogen tests based on the human fever reaction.
Schindler S; Hartung T;
Dev Biol (Basel); 2002; 111():181-6. PubMed ID: 12678239
[TBL] [Abstract][Full Text] [Related]
7. [Replacement of the pyrogen-test as batch control test for the biological substances aprotinin and urokinase].
Diehl KH
ALTEX; 2001; 18(2):107-9. PubMed ID: 11378683
[TBL] [Abstract][Full Text] [Related]
8. International validation of novel pyrogen tests based on human monocytoid cells.
Hoffmann S; Peterbauer A; Schindler S; Fennrich S; Poole S; Mistry Y; Montag-Lessing T; Spreitzer I; Löschner B; van Aalderen M; Bos R; Gommer M; Nibbeling R; Werner-Felmayer G; Loitzl P; Jungi T; Brcic M; Brügger P; Frey E; Bowe G; Casado J; Coecke S; de Lange J; Mogster B; Naess LM; Aaberge IS; Wendel A; Hartung T
J Immunol Methods; 2005 Mar; 298(1-2):161-73. PubMed ID: 15847806
[TBL] [Abstract][Full Text] [Related]
9. Detection of endotoxins and other pyrogens using human whole blood.
Fennrich S; Fischer M; Hartung T; Lexa P; Montag-Lessing T; Sonntag HG; Weigandt M; Wendel A
Dev Biol Stand; 1999; 101():131-9. PubMed ID: 10566786
[TBL] [Abstract][Full Text] [Related]
10. Alternatives to animal testing: achievements and recent developments in the European Pharmacopoeia.
Castle P
Dev Biol Stand; 1996; 86():21-9. PubMed ID: 8785951
[TBL] [Abstract][Full Text] [Related]
11. An in vitro pyrogen safety test for immune-stimulating components on surfaces.
Hasiwa M; Kullmann K; von Aulock S; Klein C; Hartung T
Biomaterials; 2007 Mar; 28(7):1367-75. PubMed ID: 17157907
[TBL] [Abstract][Full Text] [Related]
12. High sensitivity pyrogen testing in water and dialysis solutions.
Daneshian M; Wendel A; Hartung T; von Aulock S
J Immunol Methods; 2008 Jul; 336(1):64-70. PubMed ID: 18474369
[TBL] [Abstract][Full Text] [Related]
13. Optimisation of pyrogen testing in parenterals according to different pharmacopoeias by probabilistic modelling.
Hoffmann S; Luderitz-Puchel U; Montag T; Hartung T
J Endotoxin Res; 2005; 11(1):25-31. PubMed ID: 15826375
[TBL] [Abstract][Full Text] [Related]
14. Development, validation and applications of the monocyte activation test for pyrogens based on human whole blood.
Schindler S; von Aulock S; Daneshian M; Hartung T
ALTEX; 2009; 26(4):265-77. PubMed ID: 20383472
[TBL] [Abstract][Full Text] [Related]
15. Evaluation and further development of a pyrogenicity assay based on human whole blood.
Fennrich S; Fischer M; Hartung T; Lexa P; Montag-Lessing T; Sonntag HG; Weigandt M; Wendel A
ALTEX; 1998; 15(3):123-128. PubMed ID: 11178510
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of rabbit pyrogen test and human whole blood assay on human serum albumin.
Spreitzer I; Fischer M; Hartzsch K; Lüderitz-Püchel U; Montag T
ALTEX; 2002; 19 Suppl 1():73-5. PubMed ID: 12096333
[TBL] [Abstract][Full Text] [Related]
17. [LAL (Limulus Amoebocyte Lysate) test as applied to the safety evaluation of biological preparations].
Aleksandrowicz J; Kudelski Z
Rocz Panstw Zakl Hig; 1997; 48(3):275-82. PubMed ID: 9432705
[TBL] [Abstract][Full Text] [Related]
18. Development and evaluation of a pyrogen test based on human whole blood.
Hartung T; Fennrich S; Fischer M; Montag-Lessing T; Wendel A
ALTEX; 1998; 15(5):9-10. PubMed ID: 11178526
[TBL] [Abstract][Full Text] [Related]
19. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
20. Applicability of the Monocyte Activation Test (MAT) in the quality control of the 17DD yellow fever vaccine.
de Mattos KA; Navega ECA; Silva VF; Almeida AS; da Silva CC; Presgrave OAF; Junior DDSG; Delgado IF
Altern Lab Anim; 2018 Mar; 46(1):23-37. PubMed ID: 29553795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
